Dextofisopam

Dextofisopam is the R-enantiomer of the homophthalazine tofisopam. Dextofisopam can be studied in research on irritable bowel syndrome and inflammatory bowel disease[1].

Product Specifications

CAS Number

[82059-50-5]

UNSPSC

12352005

Target

Biochemical Assay Reagents

Related Pathways

Others

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Smiles

CC1=NN=C(C2=CC=C(OC)C(OC)=C2)C3=CC(OC)=C(OC)C=C3[C@H]1CC

Molecular Formula

C22H26N2O4

Molecular Weight

382.45

References & Citations

[1]Leventer, Steven M., et al., THE POTENTIAL OF DEXTOFISOPAM FOR TREATMENT OF IRRITABLE BOWEL SYNDROME AND INFLAMMATORY BOWEL DISEASE. American Journal of Gastroenterology 99 () :p S279, October 2004.